EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural and functional insights into the adenosine deaminase of the type III-B CRISPR–Cas system

Zhaoxing Li iD, Jianping Kong, Wanqian Wu, Yan Duan, Ziyi Zhu, Chenyang Hua, Purui Yan, Chen Cao, Xu Cao, Yibei Xiao iD, Meiling Lu, Meirong Chen

Nucleic Acids Research · 24.02.2026 · 54 (5)

DOI: 10.1093/nar/gkag231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 17.03.2026. Verfasst von Zhaoxing Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: Adenosine Deaminase, CRISPR-Cas Systems, CRISPR-Associated Proteins, Bacterial Proteins. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Basic Research Program of Jiangsu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type III CRISPR–Cas (Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated proteins) systems confer antiviral immunity via cyclic oligoadenylate (cOA) signaling. Here, we elucidate a cooperative bacterial defense strategy involving two cOA-activated CRISPR-associated Rossmann fold (CARF)-containing effectors, adenosine deaminase CAAD and ribonuclease Csx1, in Thermoanaerobaculum aquaticum. Genomic analyses indicate widespread co-occurrence of CRISPR-associated adenosine deaminase (CAAD) with ancillary CARF-containing effectors in type III CRISPR systems, suggesting that multiple CARF-containing proteins may contribute to a coordinated cOA-dependent defense. Biochemical and structural studies reveal the intrinsic dynamics of CAAD hexamer, and demonstrate that cA4/cA6 binding stabilizes CAAD hexamers, triggering metal-ion-dependent conversion of ATP into inosine triphosphate. Concurrently, the downstream Csx1 is exclusively activated by cA4 to cleave single-stranded RNA. Strikingly, we found that both effectors are capable of degrading cA4, suggesting that this CAAD–Csx1 pair may be cross-regulated and achieve immunity through a dual-targeting mechanism: in response to infection, Csx1 degrades viral RNA while CAAD disrupts nucleotide metabolism via ATP deamination, which can be relieved via cA4 degradation when infection has been eliminated. This study proposes an enhanced defense mechanism through coordinated activation and regulation of multiple CRISPR effectors by a single signaling molecule, unveiling unprecedented complexity in CRISPR immunoregulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine DeaminaseCRISPR-Cas SystemsCRISPR-Associated ProteinsBacterial ProteinsAdenine NucleotidesAdenosine TriphosphateModels, MolecularOligoribonucleotidesRibonucleases

Substanzen

Adenosine DeaminaseAdenine NucleotidesAdenosine TriphosphateCRISPR-Associated ProteinsBacterial ProteinsOligoribonucleotidesRibonucleases

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • Chongqing Innovation Institute of China Pharmaceutical University, Chongqing 401135, China.
  • Department of Biochemistry, School of Life Science and Technology, China, Pharmaceutical University, Nanjing 211198, China.
  • School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
  • Shanghai Frontiers Science Center for Drug Target Identification and Delivery, and the Engineering Research Center of Cell and Therapeutic Antibody of the Ministry of Education, National Key Laboratory of Innovative Imm…

ORCID-Profile: Zhaoxing Li, Yibei Xiao

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Basic Research Program of Jiangsu
  • State Key Laboratory of Natural Medicines
  • China Pharmaceutical University
  • Fundamental Research Funds for the Central Universities
  • Project Program of State Key Laboratory of Natural Medicines

Zitieren

APA

Li, Z., Kong, J., Wu, W., Duan, Y., Zhu, Z., Hua, C., Yan, P., Cao, C., Cao, X., Xiao, Y., Lu, M., & Chen, M. (2026). Structural and functional insights into the adenosine deaminase of the type III-B CRISPR–Cas system. Nucleic Acids Research, 54(5). https://doi.org/10.1093/nar/gkag231

Vancouver

Li Z, Kong J, Wu W, Duan Y, Zhu Z, Hua C, et al. Structural and functional insights into the adenosine deaminase of the type III-B CRISPR–Cas system. Nucleic Acids Research. 2026;54(5). doi:10.1093/nar/gkag231

BibTeX
@article{Li2026,
  author = {Li, Zhaoxing and Kong, Jianping and Wu, Wanqian and Duan, Yan and Zhu, Ziyi and Hua, Chenyang and Yan, Purui and Cao, Chen and Cao, Xu and Xiao, Yibei and Lu, Meiling and Chen, Meirong},
  title = {Structural and functional insights into the adenosine deaminase of the type III-B CRISPR–Cas system},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {5},
  doi = {10.1093/nar/gkag231}
}
Kostenlos starten →